Alcon becomes a separately traded standalone company
On April 9, 2019 Alcon becomes a separately traded company. Novartis and Alcon are now positioned to capitalize on significant growth opportunities and focus resources on their respective businesses and strategic priorities.
Apr 09, 2019
Novartis continues transformation into a leading medicines company with completion of the Alcon spin-off.